Why focal cartilage damage is a serious problem for athletes

A knee cartilage injury does not behave like a muscle strain or a ligament sprain. Articular cartilage is avascular and hypocellular — it carries no blood supply and contains almost no cells capable of mounting a meaningful repair response. When a full-thickness focal defect forms, the body cannot fill it, and the damage compounds over time rather than resolving.

Focal chondral lesions are found in up to 34.6% of routine knee arthroscopies, and they frequently accompany ligament or meniscal injuries — meaning an athlete may have sustained cartilage damage during the same incident that tore an ACL or meniscus, only for it to be identified incidentally during surgery on the other structure.

The long-term trajectory of an untreated defect is well established. Progressive loss of sulphated glycosaminoglycans (sGAG) occurs at the lesion edges even without excessive loading, eroding the surrounding cartilage and accelerating compartmental osteoarthritis over years. A defect that produces intermittent discomfort in the first 18 months can become a source of persistent mechanical symptoms — and a far more complex surgical problem — by 36 months. For athletes, that narrowing window has direct implications for career longevity and day-to-day function.

What OATS involves and the defect sizes it targets

The procedure transfers cylindrical plugs of bone and cartilage — harvested from a low-load-bearing area of the patient's own knee, typically the periphery of the medial femoral condyle — and press-fits them into the base of the focal defect, rebuilding the joint surface from the foundation upwards. Because the graft is autologous, there is no risk of disease transmission or immunological rejection.

The critical distinction from older marrow-stimulation techniques is what grows back. Microfracture stimulates the subchondral bone to bleed, producing fibrocartilage — a structurally inferior tissue that lacks the mechanical resilience of native hyaline cartilage and tends to degrade within two to three years. OATS transplants the genuine hyaline cartilage surface directly, restoring the bone-cartilage unit rather than generating a temporary substitute.

A further practical advantage is that everything is completed in a single operation. Two-stage procedures such as ACI or MACI require a biopsy, an external cell-culture period, and a second procedure for implantation — a meaningful commitment for an athlete managing a competitive schedule.

In terms of defect size, OATS is most reliably indicated for focal lesions in the range of 1–2 cm². A multi-plug mosaicplasty configuration can extend coverage to approximately 4 cm², but evidence for defects exceeding 3–4 cm² becomes less consistent, and larger lesions may be better served by other restoration strategies. Correct patient selection — factoring in defect size, location, and knee alignment — is central to achieving durable results.

What the 10-year evidence actually shows

The strongest long-term data comes from the Gudas randomised controlled trial — the only prospective RCT in young athletes with a genuine 10-year endpoint. It recorded treatment failure in 14% of OATS patients compared with 38% in the microfracture group, and crucially that divergence widened decisively between years five and ten. Studies with follow-up shorter than five years consistently understate this advantage; mid-term data should be read with that limitation in mind.

What happens to functional scores over a decade is, in broad terms, an encouraging story. They roughly double in the first two years, hold steady for another three, then ease back modestly — but remain substantially above the pre-operative baseline throughout. The specific figures from a 2026 institutional cohort of 63 patients (mean age 27.4 years, mean lesion 2.3 cm²) map that pattern precisely: IKDC scores rose from 46.4 before surgery to 76.1 at two years, 78.0 at five years, and 70.4 at ten years, remaining statistically significant at each timepoint (P<.001). The attenuation after year five is real and worth acknowledging in pre-operative discussions rather than glossing over.

Across systematic reviews, approximately 72% of patients achieve a successful long-term outcome, with graft survival cited at between 72% and 86% at decade-length follow-up. The counter-figure deserves equal clarity: somewhere between 28% and 33% of patients face surgical failure or revision within ten years — a proportion that matters when athletes are weighing a high-stakes career decision.

One meaningful modifier is knee alignment. A combined OATS and medial open-wedge high tibial osteotomy cohort of 66 knees reached Kaplan-Meier survivorship of 96.7% at a mean follow-up of 9.49 years, with Knee Society Scores rising from 48.3 to 90.4 — a signal that correcting concurrent malalignment at the time of cartilage restoration materially improves long-term durability where it is present.

Return to sport — rates, timelines, and the competitive-level gap

Published return-to-sport rates for OATS range from 87% to 100% across 16 studies of pivoting-sport athletes — but that headline figure obscures the distinction that matters most in clinical counselling. Return to preinjury competitive level is a different, more demanding endpoint, and the evidence places it at 67–93%, already a more qualified picture. Against microfracture, the contrast is stark: microfracture return-to-sport rates in comparable cohorts run from 44% to 83%, with return to preinjury level between 25% and 75%, substantially below OATS across the full range.

The most important nuance in this body of evidence comes from long-term follow-up data spanning 10–25 years (Keszég et al., 2022). Stratified by competitive tier, the findings diverge sharply: 85% of professional athletes and 88% of recreational athletes returned to the same level of sport after OATS, but only 34% of competitive-level athletes — those competing between recreational and professional — reached the same tier again. This middle-tier gap is not explained by graft failure alone; factors including load demands, training volume, and the psychological pressures of structured competition are likely contributors. It is the figure that most directly informs pre-operative conversations with club-level or semi-professional athletes.

A broader systematic review of 52 studies involving more than 2,300 athletes places the overall return-to-sport rate across all cartilage restoration procedures at approximately 80%, with OATS consistently among the top-performing techniques. OATS also allows earlier return to play than osteochondral allograft transplantation, though specific timelines vary considerably between centres and depend on the rehabilitation protocol used — and protocols remain heterogeneous, with no single universally adopted framework.

Factors that predict durable results — and where OATS is less reliable

Several clinical factors reliably predict whether an OATS graft will remain durable at a decade. Lesion size below 2 cm², a medial femoral condyle location, younger patient age, and no prior surgery on the same knee are consistently associated with better long-term results across the evidence base. Increased age, a history of previous ipsilateral surgery, and larger defect size are the primary correlates of failure. Defects exceeding 3–4 cm² produce progressively less predictable outcomes; mosaicplasty — using multiple smaller plugs to cover a wider area — can extend the treatable range, but each additional plug increases harvest complexity and the demands on the donor site.

Lower-limb alignment deserves particular weight in pre-operative planning. Uncorrected malalignment concentrates mechanical load through the repaired surface and substantially shortens graft longevity — and, as the OATS-plus-HTO survivorship figures demonstrate, correcting it concurrently with cartilage restoration can transform the long-term picture. Alignment assessment should sit alongside lesion characterisation as standard workup rather than as an afterthought.

Donor-site morbidity is a genuine consideration that should enter every pre-operative conversation. In adult series it is reported at approximately 7.8%; one paediatric series recorded 13.5% of patients requiring secondary surgery, all for fibrocartilage overgrowth at the harvest site. These are manageable and addressable complications, but they are not trivial.

Two evidence gaps are worth stating honestly. No RCT-level comparison of OATS against autologous chondrocyte implantation or osteochondral allograft exists at the 10-year mark specifically in competitive athletes — the Gudas trial remains singular. And evidence in female athletes and sports defined by repetitive loading, such as distance running and cycling, is sparse. These are limitations of the current literature, not contraindications.

Where OATS fits in the wider knee cartilage repair pathway

Choosing the right cartilage procedure rests on matching the defect to the technique — and that requires precise mapping before any surgical plan is made. The pathway moves through four stages: symptom management, biologic or injection support, cartilage restoration surgery, and joint replacement if preservation eventually fails. OATS occupies the third stage for focal, contained lesions, typically 1–2 cm² with mosaicplasty extending coverage to roughly 4 cm².

Defect size is the clearest branch-point. Where autograft harvest would be insufficient for a lesion above 2 cm², MACI or ACI — which use the patient's cultured chondrocytes seeded onto a collagen membrane — are generally more appropriate. Larger or posttraumatic defects may require osteochondral allograft instead. What OATS is not suited to is diffuse or advanced osteoarthritis; the technique depends on healthy surrounding tissue to function as a containment boundary.

BMAC augmentation combined with a structured minimum 12-week rehabilitation protocol has been shown to improve MOCART 2.0 cartilage repair scores meaningfully — making these not optional extras but part of a complete OATS pathway.

For athletes working through this decision, the technique choice ultimately hinges on what the cartilage imaging actually shows: lesion grade, subchondral status, compartment integrity, and alignment. Lincolnshire Knee, part of the MSK Doctors group, offers consultant assessment without a GP referral — including onMRI™ AI-driven cartilage analysis and T2 mapping to define lesion characteristics and guide technique selection. Further information is available at lincolnshireknee.co.uk.

1. [1] Midterm Outcomes of Primary Osteochondral Autograft Transfer for Symptomatic Chondral Defects of the Knee. (2026). https://pmc.ncbi.nlm.nih.gov/articles/PMC12811580/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12811580/
2. [2] Treatment options and outcomes for paediatric knee cartilage lesions: a systematic review. (2025). https://doi.org/10.1016/j.knee.2025.08.020 https://doi.org/10.1016/j.knee.2025.08.020
3. [3] Favorable 10-year outcomes of osteochondral autologous transplantation for spontaneous osteonecrosis of the knee following subchondral insufficiency fracture with optimal alignment correction. (2025). https://doi.org/10.1186/s43019-025-00285-2 https://doi.org/10.1186/s43019-025-00285-2
4. [4] Randomised prospective study of functional outcomes: ACL reconstruction with OATS vs ACL reconstruction with microfracture. (2023). https://doi.org/10.36106/ijsr/5106290 https://doi.org/10.36106/ijsr/5106290
5. [5] Return to Pivoting Sports after Cartilage Repair Surgery of the Knee: A Scoping Review. (2023). https://pmc.ncbi.nlm.nih.gov/articles/PMC10076897/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10076897/
6. [6] OATS Harvesting from the Femoral Condyle is not Benign: Knee Outcomes after OATS vs OCA for Elbow OCD in Children. (2026). https://doi.org/10.1177/2325967126s00127 https://doi.org/10.1177/2325967126s00127
7. [7] Evaluating single-stage cartilage treatments in the knee: A systematic review and meta-analysis of OATS and minced cartilage repair (MCR) techniques. (2026). https://doi.org/10.1016/j.jor.2025.12.052 https://doi.org/10.1016/j.jor.2025.12.052